SEC Form 4 · accession 0000921895-17-002954
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dhruwa N Rai
Director
Period of report
Dec 21, 2017
Accepted (ET)
Dec 26, 2017 · 2:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 21, 2017 | M | 333,333 | — | A | 982,112 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Dec 21, 2017 | M | 333,333 | D | — | — | Common Stock | 333,333 | 0 | D |
Explanation of responses
- F1Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2015 Equity Incentive Award Plan (the "Plan") on May 10, 2016 (the "2016 Grant"). Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The indicated RSUs vested in full on December 21, 2017, due to the determination of the Issuer to accelerate vesting of the RSUs in accordance with the terms of the Plan and a RSU Agreement between the Issuer and the Reporting Person.
- F2The Reporting Person previously agreed to cancel 166,667 RSUs granted pursuant to the 2016 Grant.